Home  /  Resource Library  /  Phase 2, multicenter GIBB study of obinutuzumab plus bendamustine in previously untreated patients with chronic lymphocytic leukemia

Phase 2, multicenter GIBB study of obinutuzumab plus bendamustine in previously untreated patients with chronic lymphocytic leukemia

Results of a phase II study examining obinutuzumab combined with bendamustine for first line treatment of CLL.